Furthermore, in light of the fact that normal tissue stem cells express ABC transporters, as well as other multi-drug resistance genes, attempts to impact the tumor stem cell population via MDR reversal agents may damage the normal tissue stem cell population, counteracting potential increases in therapeutic index [41]. Here, ABCG2 is linked to neoplasm.